NASDAQ: CODX
Co Diagnostics Inc Stock Forecast, Predictions & Price Target

Analyst price target for CODX

Based on 2 analysts offering 12 month price targets for Co Diagnostics Inc

Min Forecast
$45.00+2,822.08%
Avg Forecast
$67.50+4,283.12%
Max Forecast
$90.00+5,744.16%

Should I buy or sell CODX stock?

Based on 2 analysts offering ratings for Co Diagnostics Inc.

Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CODX stock forecasts and price targets.

CODX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-26
lockedlocked$00.00+00.00%2025-10-28

1 of 1

Forecast return on equity

Is CODX forecast to generate an efficient return?

Company
117.56%
Industry
29.46%
Market
178.05%
CODX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CODX forecast to generate an efficient return on assets?

Company
98.02%
Industry
14.97%
CODX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CODX earnings per share forecast

What is CODX's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$12.39
Avg 2 year Forecast
-$12.24
Avg 3 year Forecast
$14.38

CODX revenue forecast

What is CODX's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$587.5k-5.62%
Avg 2 year Forecast
$17.5M+2,716.11%
Avg 3 year Forecast
$60.6M+9,627.4%
CODX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CODX revenue growth forecast

How is CODX forecast to perform vs Medical Devices companies and vs the US market?

Company
348.12%
Industry
9.06%
Market
13.79%
CODX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CODX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CODX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
CODX$1.54$67.50+4,283.12%Strong Buy
ITOC$0.31N/AN/A
BMRA$2.17N/AN/A
AMIX$0.40$2.00+406.33%Strong Buy
INBS$2.75N/AN/A

Co Diagnostics Stock Forecast FAQ

Is Co Diagnostics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CODX) stock is to Strong Buy CODX stock.

Out of 2 analysts, 2 (100%) are recommending CODX as a Strong Buy, 0 (0%) are recommending CODX as a Buy, 0 (0%) are recommending CODX as a Hold, 0 (0%) are recommending CODX as a Sell, and 0 (0%) are recommending CODX as a Strong Sell.

If you're new to stock investing, here's how to buy Co Diagnostics stock.

What is CODX's earnings growth forecast for 2026-2028?

(NASDAQ: CODX) Co Diagnostics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 24.08%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.03%.

Co Diagnostics's earnings in 2026 is -$46,895,936.On average, 4 Wall Street analysts forecast CODX's earnings for 2026 to be -$44,645,349, with the lowest CODX earnings forecast at -$47,660,612, and the highest CODX earnings forecast at -$40,851,953. On average, 3 Wall Street analysts forecast CODX's earnings for 2027 to be -$44,094,172, with the lowest CODX earnings forecast at -$42,364,988, and the highest CODX earnings forecast at -$45,391,059.

In 2028, CODX is forecast to generate $51,815,833 in earnings, with the lowest earnings forecast at $49,783,840 and the highest earnings forecast at $53,339,828.

What is CODX's revenue growth forecast for 2026-2028?

(NASDAQ: CODX) Co Diagnostics's forecast annual revenue growth rate of 348.12% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.06%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.79%.

Co Diagnostics's revenue in 2026 is $622,489.On average, 4 Wall Street analysts forecast CODX's revenue for 2026 to be $2,116,520, with the lowest CODX revenue forecast at $1,948,789, and the highest CODX revenue forecast at $2,269,553. On average, 3 Wall Street analysts forecast CODX's revenue for 2027 to be $63,151,211, with the lowest CODX revenue forecast at $60,672,716, and the highest CODX revenue forecast at $65,006,481.

In 2028, CODX is forecast to generate $218,136,461 in revenue, with the lowest revenue forecast at $209,584,209 and the highest revenue forecast at $224,552,451.

What is CODX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: CODX) forecast ROA is 98.02%, which is higher than the forecast US Medical Devices industry average of 14.97%.

What is CODX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CODX price target, the average CODX price target is $67.50, with the highest CODX stock price forecast at $90.00 and the lowest CODX stock price forecast at $45.00.

On average, Wall Street analysts predict that Co Diagnostics's share price could reach $67.50 by Nov 26, 2026. The average Co Diagnostics stock price prediction forecasts a potential upside of 4,283.12% from the current CODX share price of $1.54.

What is CODX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: CODX) Co Diagnostics's current Earnings Per Share (EPS) is -$35.25. On average, analysts forecast that CODX's EPS will be -$12.39 for 2026, with the lowest EPS forecast at -$13.23, and the highest EPS forecast at -$11.34. On average, analysts forecast that CODX's EPS will be -$12.24 for 2027, with the lowest EPS forecast at -$11.76, and the highest EPS forecast at -$12.60. In 2028, CODX's EPS is forecast to hit $14.38 (min: $13.82, max: $14.81).

What is CODX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: CODX) forecast ROE is 117.56%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.